"We seek to grow and operate as a positive member in our market and society"
We are a Greek pharmaceutical company established with the vision to offer a better quality of life to thousands of patients living with threatening and rare diseases through innovative treatments. It is a purpose that creates a special sense of responsibility and shapes the overall ‘personality’ of the company.
What we seek is to be a model company overall, to grow and operate as a positive member in our market and the society at large, creating value for our company, but also for those around us.
Our choice for growth is based on the values of responsibility, integrity, quality and added value for the medical community and patients, our people and our international partners. These values are an integral part of our strategy, but also of the corporate goals and procedures based on which we operate daily, since it is important to be put into practice by all of us at GENESIS Pharma.
At the same time, we are constantly strengthening our social contribution, which does not only include health and prevention activities, but also extends to social issues that we consider very important and concern equal opportunities and education of children, as well as the support of vulnerable social groups.
Overall, our contribution in the national economy and society exceeds 30% of our annual turnover. What we aim is for our commitments and the actions we undertake to have continuity in time, but also to strengthen our investment as our company grows.
Mr. Konstantinos Evripides, CEO
At the heart of GENESIS Pharma’s operation lays patient access to high quality and safety treatments and its cooperation with the medical & pharma community based on scientific value and transparency. The company invests in importing to Greece innovative and orphan drugs that address unmet therapeutic needs, it applies a comprehensive quality and safety policy, as well as internal regulatory and ethical compliance procedures with the strictest international standards.
It also implements an environmental plan that focuses on the safe management of expired medicines or damaged stock and the sustainable use of natural resources and energy in its day-to-day operation.
Its work environment, which aims to make its people feel safe and provide them with development prospects and recognition, is the most awarded in Greece in the Best Workplaces competition that is based on the evaluation of the employees themselves. Practices that ensure open communication and cooperation, benefits and moral reward, meritocracy, continuing education, health and safety, but also the support of working mothers and the families of its people have been part of its HR program for many years.
At the same time, for more than 15 years, the company has been implementing an extensive social contribution program. It supports numerous patient associations and NGOs that serve patients and undertakes disease awareness activities. It also implements programs addressed to children and the young generation mainly related to education and equal opportunities, as well as rewarding excellence and promoting sports. Indicatively, GENESIS Pharma implements the long-term program 'Generous School' for infrastructure upgrades and small-scale renovation of schools in the Attica region and the program 'Generous Knowledge' through which schools in remote islands and areas all over Greece are supported with educational technology equipment. In recent years, GENESIS Pharma has significantly strengthened its investment in solidarity actions, addressing special social needs. The company has been participating in the Program ‘DIATROFI (Nutrition)’ implemented by the Prolepsis Institute to address child food insecurity. Through ‘DIATROFI’, GENESIS Pharma has offered 40,260 healthy meals to more than 450 children in schools of Attica during the last years. Its employees also contribute significantly to the company’s social commitment, via the voluntary team GENEROUS, created to help NGOs and institutions in need.
GENESIS Pharma’s financial contribution to the Greek economy and society from taxes and levies, wages and benefits to its employees as well as its social contribution program, exceeds 30% of the company’s annual turnover. Indicatively, 40% of the company’s total invoiced sales in 2019 returned to the National Healthcare System as clawback & rebates, while for 2018, the respective percentage was 35%.